TET2 regulation of alcoholic fatty liver via Srebp1 mRNA in paraspeckles

被引:2
|
作者
Li, Qinjin [1 ]
Pan, Yanyan [1 ]
Zhang, Jing [1 ]
Hu, Boxu [1 ]
Qin, Dan [1 ]
Liu, Shenghui [1 ]
Chen, Ning [1 ]
Zhang, Lisheng [1 ]
机构
[1] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR-MECHANISMS; GENE-EXPRESSION; PROMOTES; TRANSLATION; METHYLTRANSFERASE; DIFFERENTIATION; CONSUMPTION; BIOMARKERS; DYNAMICS; DISEASE;
D O I
10.1016/j.isci.2024.109278
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epigenetic modifications have emerged as key regulators of metabolism -related complex diseases including the alcoholic fatty liver disease (AFLD) prevalent chronic liver disorder with significant economic implications. Building upon previous research that emphasizes ten -eleven translocation (TET) proteins' involvement in adipocyte insulin sensitization and fatty acid oxidation, we explored the role of TET2 protein in AFLD pathogenesis which catalyzes 5-methylcytosine into 5-hydroxymethylcytosine in DNA/RNA. Our findings revealed that TET2 deficiency exacerbates AFLD progression. And TET2 influenced the expression and activity of sterol regulatory element binding protein 1 (SREBP1), a key regulator of hepatic lipid synthesis, by modulating Srebp1 mRNA retention. Employing RIP-qPCR and bisulfite sequencing techniques, we provided evidence of TET2-mediated epigenetic modifications on Srebp1 mRNA, thereby affecting lipid metabolism. Through elucidating the role of methylation in RNA nuclear retention via paraspeckles, our study enhances understanding of AFLD pathogenesis from an epigenetic perspective, paving the way for identifying potential therapeutic targets.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway
    Quan, Hai Yan
    Kim, Do Yeon
    Kim, Soo Jung
    Jo, Hee Kyung
    Kim, Go Woon
    Chung, Sung Hyun
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (09) : 1330 - 1340
  • [2] Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
    Wang, Yan-Gui
    Yang, Tian-Lun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1777 - 1783
  • [3] Nuclear factor Y participates in alcoholic liver disease by activating SREBP1 expression in mice
    Zhang, Yanjie
    Sun, Yajun
    Zhang, Yange
    Miao, Qin
    Wang, Qi
    Yang, Bin
    Li, Yanzhong
    Li, Lin
    Zhang, Ruiling
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 541 : 90 - 94
  • [4] FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
    Ke, Changle
    Xiao, Changchen
    Li, Jiamin
    Wu, Xianpeng
    Zhang, Yu
    Chen, Yongjian
    Sheng, Shuyuan
    Fu, Zaiyang
    Wang, Lingjun
    Ni, Cheng
    Zhao, Jing
    Shi, Yanna
    Wu, Yan
    Zhong, Zhiwei
    Nan, Jinliang
    Zhu, Wei
    Chen, Jinghai
    Wu, Rongrong
    Hu, Xinyang
    HEPATOLOGY, 2025, 81 (01) : 181 - 197
  • [5] The active nuclear form of SREBP1 amplifies ER stress and autophagy via regulation of PERK
    Hu, Qin
    Mao, Yu
    Liu, Min
    Luo, Rui
    Jiang, Rong
    Guo, Fengjin
    FEBS JOURNAL, 2020, 287 (11) : 2348 - 2366
  • [6] Activation of liver X receptor promotes fatty acid synthesis in goat mammary epithelial cells via modulation of SREBP1 expression
    Xu, H. F.
    Luo, J.
    Zhang, X. Y.
    Li, J.
    Bionaz, M.
    JOURNAL OF DAIRY SCIENCE, 2019, 102 (04) : 3544 - 3555
  • [7] Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1
    Kim, JB
    Sarraf, P
    Wright, M
    Yao, KM
    Mueller, E
    Solanes, G
    Lowell, BB
    Spiegelman, BM
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01): : 1 - 9
  • [8] Regulation of the bovine SCD5 promoter by EGR2 and SREBP1
    Lengi, Andrea J.
    Corl, Benjamin A.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 421 (02) : 375 - 379
  • [9] Ilexgenin A restrains CRTC2 in the cytoplasm to prevent SREBP1 maturation via AMP kinase activation in the liver
    Lu, Yawen
    Ma, Jingjie
    Li, Ping
    Liu, Baolin
    Wen, Xiaodong
    Yang, Jie
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (05) : 958 - 978
  • [10] HBV replication increases cholesterols via upregulation of SREBP-2/HMGCR and down-regulation of CYP-7α in alcoholic fatty liver mice
    Wang, Yaqi
    Wang, Honqwu
    Wu, Ting
    Hu, Danqing
    Weng, Xingxing
    Chen, Pei-Jer
    Luo, Xiaoping
    Ning, Qin
    HEPATOLOGY, 2016, 64 : 615A - 616A